# Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

> **NCT01436110** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 351 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone furoate 50mcg
- **DRUG:** Fluticasone propionate 100mcg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01436110
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 351 (ACTUAL)
- **Last updated:** 2017-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436110, "Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01436110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*